vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and National Storage Affiliates Trust (NSA). Click either name above to swap in a different company.
National Storage Affiliates Trust is the larger business by last-quarter revenue ($187.0M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -1.6%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -2.4%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
National Storage Affiliates Trust is a U.S.-headquartered real estate investment trust focused on self-storage assets. It owns, operates and acquires self-storage facilities across dozens of U.S. states, offering secure storage solutions for residential and commercial customers.
ESPR vs NSA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $187.0M |
| Net Profit | — | $22.9M |
| Gross Margin | — | 72.5% |
| Operating Margin | 50.6% | 20.2% |
| Net Margin | — | 12.2% |
| Revenue YoY | 143.7% | -1.6% |
| Net Profit YoY | — | 36.8% |
| EPS (diluted) | $0.32 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $187.0M | ||
| Q3 25 | $87.3M | $188.7M | ||
| Q2 25 | $82.4M | $188.8M | ||
| Q1 25 | $65.0M | $188.4M | ||
| Q4 24 | $69.1M | $190.1M | ||
| Q3 24 | $51.6M | $193.6M | ||
| Q2 24 | $73.8M | $190.4M | ||
| Q1 24 | $137.7M | $196.1M |
| Q4 25 | — | $22.9M | ||
| Q3 25 | $-31.3M | $18.4M | ||
| Q2 25 | $-12.7M | $19.5M | ||
| Q1 25 | $-40.5M | $13.0M | ||
| Q4 24 | — | $16.7M | ||
| Q3 24 | $-29.5M | $18.7M | ||
| Q2 24 | $-61.9M | $17.1M | ||
| Q1 24 | $61.0M | $59.0M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 70.7% | ||
| Q2 25 | — | 70.5% | ||
| Q1 25 | — | 70.7% | ||
| Q4 24 | — | 72.5% | ||
| Q3 24 | — | 72.8% | ||
| Q2 24 | — | 72.6% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 50.6% | 20.2% | ||
| Q3 25 | -11.4% | 15.8% | ||
| Q2 25 | 8.6% | 16.5% | ||
| Q1 25 | -34.0% | 11.0% | ||
| Q4 24 | -6.4% | 14.5% | ||
| Q3 24 | -31.0% | 15.8% | ||
| Q2 24 | 3.5% | 17.2% | ||
| Q1 24 | 52.5% | 48.9% |
| Q4 25 | — | 12.2% | ||
| Q3 25 | -35.9% | 9.8% | ||
| Q2 25 | -15.4% | 10.3% | ||
| Q1 25 | -62.2% | 6.9% | ||
| Q4 24 | — | 8.8% | ||
| Q3 24 | -57.2% | 9.7% | ||
| Q2 24 | -83.9% | 9.0% | ||
| Q1 24 | 44.3% | 30.1% |
| Q4 25 | $0.32 | $0.23 | ||
| Q3 25 | $-0.16 | $0.17 | ||
| Q2 25 | $-0.06 | $0.19 | ||
| Q1 25 | $-0.21 | $0.10 | ||
| Q4 24 | $-0.14 | $0.19 | ||
| Q3 24 | $-0.15 | $0.18 | ||
| Q2 24 | $-0.33 | $0.16 | ||
| Q1 24 | $0.34 | $0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $23.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $946.0M |
| Total Assets | $465.9M | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $23.3M | ||
| Q3 25 | $92.4M | $26.3M | ||
| Q2 25 | $86.1M | $26.1M | ||
| Q1 25 | $114.6M | $19.3M | ||
| Q4 24 | $144.8M | $50.4M | ||
| Q3 24 | $144.7M | $69.9M | ||
| Q2 24 | $189.3M | $59.0M | ||
| Q1 24 | $226.6M | $64.2M |
| Q4 25 | $-302.0M | $946.0M | ||
| Q3 25 | $-451.4M | $973.1M | ||
| Q2 25 | $-433.5M | $1.0B | ||
| Q1 25 | $-426.2M | $1.0B | ||
| Q4 24 | $-388.7M | $1.1B | ||
| Q3 24 | $-370.2M | $986.9M | ||
| Q2 24 | $-344.2M | $1.2B | ||
| Q1 24 | $-294.3M | $1.3B |
| Q4 25 | $465.9M | $5.1B | ||
| Q3 25 | $364.0M | $5.1B | ||
| Q2 25 | $347.1M | $5.2B | ||
| Q1 25 | $324.0M | $5.3B | ||
| Q4 24 | $343.8M | $5.4B | ||
| Q3 24 | $314.1M | $5.4B | ||
| Q2 24 | $352.3M | $5.3B | ||
| Q1 24 | $373.1M | $5.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $338.5M |
| Free Cash FlowOCF − Capex | — | $299.8M |
| FCF MarginFCF / Revenue | — | 160.3% |
| Capex IntensityCapex / Revenue | 0.0% | 20.7% |
| Cash ConversionOCF / Net Profit | — | 14.79× |
| TTM Free Cash FlowTrailing 4 quarters | — | $541.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $338.5M | ||
| Q3 25 | $-4.3M | $100.2M | ||
| Q2 25 | $-31.4M | $79.9M | ||
| Q1 25 | $-22.6M | $85.6M | ||
| Q4 24 | $-35.0M | $363.1M | ||
| Q3 24 | $-35.3M | $105.7M | ||
| Q2 24 | $-7.2M | $83.2M | ||
| Q1 24 | $53.8M | $94.0M |
| Q4 25 | — | $299.8M | ||
| Q3 25 | — | $88.0M | ||
| Q2 25 | — | $73.8M | ||
| Q1 25 | — | $79.9M | ||
| Q4 24 | — | $344.4M | ||
| Q3 24 | $-35.5M | $101.8M | ||
| Q2 24 | $-7.3M | $79.5M | ||
| Q1 24 | $53.8M | $88.6M |
| Q4 25 | — | 160.3% | ||
| Q3 25 | — | 46.6% | ||
| Q2 25 | — | 39.1% | ||
| Q1 25 | — | 42.4% | ||
| Q4 24 | — | 181.2% | ||
| Q3 24 | -68.7% | 52.6% | ||
| Q2 24 | -9.9% | 41.7% | ||
| Q1 24 | 39.0% | 45.2% |
| Q4 25 | 0.0% | 20.7% | ||
| Q3 25 | 0.0% | 6.5% | ||
| Q2 25 | 0.0% | 3.2% | ||
| Q1 25 | 0.0% | 3.0% | ||
| Q4 24 | 0.0% | 9.8% | ||
| Q3 24 | 0.3% | 2.0% | ||
| Q2 24 | 0.1% | 1.9% | ||
| Q1 24 | 0.1% | 2.7% |
| Q4 25 | — | 14.79× | ||
| Q3 25 | — | 5.44× | ||
| Q2 25 | — | 4.10× | ||
| Q1 25 | — | 6.59× | ||
| Q4 24 | — | 21.70× | ||
| Q3 24 | — | 5.65× | ||
| Q2 24 | — | 4.88× | ||
| Q1 24 | 0.88× | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
NSA
Segment breakdown not available.
